DIFFERENTIAL EXPRESSION OF VIRAL AND HUMAN INTERLEUKIN-10 (IL-10) BY PRIMARY B-CELL TUMORS AND B-CELL LINES

被引:54
|
作者
STEWART, JP
BEHM, FG
ARRAND, JR
ROONEY, CM
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT PATHOL, MEMPHIS, TN 38101 USA
[2] CHRISTIE CRC CANC CTR, PATERSON INST CANC RES, DEPT MOLEC BIOL, MANCHESTER M20 9BX, LANCS, ENGLAND
[3] UNIV TENNESSEE, DEPT PATHOL, MEMPHIS, TN USA
关键词
D O I
10.1006/viro.1994.1236
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human and viral interleukin-10 (IL-10) possess growth factor activity for human B cells and may act as autocrine growth factors in B cell malignancies. To study this possibility we have measured viral (v) and human (h) IL-10 expression in EBV-positive and negative B lineage tumors and tumor cell lines. Previous studies demonstrated IL-10 expression in cell lines and now we describe the pattern of IL-10 expression in primary Burkitt's lymphoma (BL) tumor biopsies and in BL lines of defined phenotypes, vIL-10 was expressed during the lytic (productive) phase of EBV infection, but not during virus latency. Although hIL-10 was expressed in the majority of B cell lines, it was not expressed in two BL biopsy specimens. Expression of hIL-10 did not correlate with the presence of EBV, but was associated with the differentiation stare of the B cell line. Thus, vIL-10 may enhance the persistence of B cells infected at sites of virus replication, and while hIL-10 may be a factor in the growth both in vivo and in vitro of some BLs and EBV-transformed B cells, it is not an absolute requirement. (C) 1994 Academic Press, Inc.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 50 条
  • [1] INTERLEUKIN-10 IN HUMAN B-CELL DIFFERENTIATION
    LI, L
    XIA, X
    CHOI, YS
    FASEB JOURNAL, 1994, 8 (04): : A256 - A256
  • [2] Differential effects of viral IL-10 and human IL-10 on human B cell lines.
    Beatty, PR
    Krama, SM
    Bromberg, JS
    Martinez, OM
    FASEB JOURNAL, 1998, 12 (04): : A265 - A265
  • [3] A review of the association between interleukin-10 and human B-cell malignancies
    Vijay P. Khatri
    Michael A. Caligiuri
    Cancer Immunology, Immunotherapy, 1998, 46 : 239 - 244
  • [4] A review of the association between interleukin-10 and human B-cell malignancies
    Khatri, VP
    Caligiuri, MA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (05) : 239 - 244
  • [5] Interleukin-10 (IL-10) mRNA expression in B-cell chronic lymphocytic leukemia (B-CLL) inversely correlates with progression of disease.
    Sjoberg, J
    AguilarSantelises, M
    Sjogren, AM
    Pisa, EK
    Ljungdahl, A
    Bjorkholm, M
    Jondal, M
    Mellstedt, H
    Pisa, P
    BLOOD, 1995, 86 (10) : 3358 - 3358
  • [6] HUMAN B-CELL INTERLEUKIN-10 - B-CELL LINES DERIVED FROM PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND BURKITTS-LYMPHOMA CONSTITUTIVELY SECRETE LARGE QUANTITIES OF INTERLEUKIN-10
    BENJAMIN, D
    KNOBLOCH, TJ
    DAYTON, MA
    BLOOD, 1992, 80 (05) : 1289 - 1298
  • [7] THE ROLE OF IL-10 IN HUMAN B-CELL ACTIVATION, PROLIFERATION, AND DIFFERENTIATION
    ITOH, K
    HIROHATA, S
    JOURNAL OF IMMUNOLOGY, 1995, 154 (09): : 4341 - 4350
  • [8] B-cell production of IL-10 is gender and strain dependent
    da Rosa, L. C.
    De Leenheer, E.
    Wong, F. S.
    IMMUNOLOGY, 2014, 143 : 164 - 164
  • [9] Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells
    Jurlander, J
    Lai, CF
    Tan, J
    Chou, CC
    Geisler, CH
    Schriber, J
    Blumenson, LE
    Narula, SK
    Baumann, H
    Caligiuri, MA
    BLOOD, 1997, 89 (11) : 4146 - 4152
  • [10] The immune modulation of B-cell responses by Porphyromonas gingivalis and interleukin-10
    Champaiboon, C
    Yongvanitchit, K
    Pichyangkul, S
    Mahanonda, R
    JOURNAL OF PERIODONTOLOGY, 2000, 71 (03) : 468 - 475